Literature DB >> 27847194

Small HDL subclasses become cholesterol-poor during postprandial period after a fat diet intake in subjects with high triglyceridemia increases.

Armando Quintanilla-Cantú1, Paola Peña-de-la-Sancha1, Cristobal Flores-Castillo1, Ana María Mejía-Domínguez2, Rosalinda Posadas-Sánchez3, Nonanzit Pérez-Hernández1, Rocío Bautista-Pérez1, Reyna Esmeralda Enriquez-Calderón4, Marco Antonio Juárez-Oropeza5, José Manuel Fragoso1, Gilberto Vargas-Alarcón1, Oscar Pérez-Méndez6.   

Abstract

BACKGROUND: Postprandial triglyceridemia may transitory affect the structure of HDL subclasses and probably their antiatherogenic properties but little is known in this field. We analyzed the HDL subclasses lipid content along postprandial period.
METHODS: Fifteen metabolic syndrome (MS) patients and 15 healthy controls were enrolled. HDL were isolated from plasma samples obtained at fasting and every 2-h up to 8-h, after a 75-g fat meal. Cholesterol (C), triglycerides (TAG), and phospholipid (Ph) plasma concentrations of five HDL subclasses were determined by densitometry of electrophoresis gels enzymatically stained.
RESULTS: The increase of postprandial triglyceridemia expressed as the incremental area under the curve (iAUC) was twice in MS patients than in controls. Only large HDL2b-TAG were higher in MS than controls at 4, 6 and 8h after meal intake, whereas cholesterol of HDL2a, 3a and 3b were lower at 8h. HDL size distribution shifted towards large HDL and HDL3a-, 3b- and 3c-subclasses had a lower content of cholesterol (estimated by the C-to-Ph ratio) in subjects whose iAUC>289.5mgh/dl (n=15) in comparison with those subjects with iAUC below this cutoff point (n=15), independently of the MS status and fasting TAG. Triglycerides content of HDL subclasses changed only discreetly along the postprandial period, whereas paraoxonase-1 remained unchanged.
CONCLUSIONS: A high postprandial triglyceridemia conditions the shift of HDL size distribution towards large particles and the decrease of cholesterol in HDL3 subclasses. These data demonstrate that postprandial hypertriglyceridemia contributes to a transitory hypoalphalipoproteinemia that may increase the risk of cardiovascular disease.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Coronary heart disease; HDL subclasses; Hypertriglyceridemia; Hypoalphalipoproteinemia; Lipoprotein metabolism; Metabolic syndrome; Postprandial state

Mesh:

Substances:

Year:  2016        PMID: 27847194     DOI: 10.1016/j.cca.2016.11.018

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  The rs4783961 and rs708272 genetic variants of the CETP gene are associated with coronary artery disease, but not with restenosis after coronary stenting.

Authors:  Gilberto Vargas-Alarcón; Oscar Pérez-Méndez; Rosalinda Posadas-Sánchez; Marco A Peña-Duque; Marco A Martínez-Ríos; Hilda Delgadillo-Rodriguez; José M Fragoso
Journal:  Arch Cardiol Mex       Date:  2022-07-01

2.  Microencapsulated Pomegranate Modifies the Composition and Function of High-Density Lipoproteins (HDL) in New Zealand Rabbits.

Authors:  Alan Dorantes-Morales; Diego Estrada-Luna; Rocío Bautista-Pérez; Gabriel Betanzos-Cabrera; María Luna-Luna; Cristóbal Flores-Castillo; Gilberto Vargas-Alarcón; José Manuel Fragoso; Óscar Pérez-Méndez; Elizabeth Carreón-Torres
Journal:  Molecules       Date:  2020-07-21       Impact factor: 4.411

3.  The Association Between an Addictive Tendency Toward Food and Metabolic Characteristics in the General Newfoundland Population.

Authors:  Matthew Nelder; Farrell Cahill; Hongwei Zhang; Guangju Zhai; Wayne Gulliver; Weiping Teng; Zhongyan Shan; Guang Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-09       Impact factor: 5.555

Review 4.  Hypertriglyceridemia and atherosclerosis.

Authors:  Jia Peng; Fei Luo; Guiyun Ruan; Ran Peng; Xiangping Li
Journal:  Lipids Health Dis       Date:  2017-12-06       Impact factor: 3.876

Review 5.  High Density Lipoproteins: Metabolism, Function, and Therapeutic Potential.

Authors:  Anne Jomard; Elena Osto
Journal:  Front Cardiovasc Med       Date:  2020-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.